NCT06940388
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06940388
Title Total Neoadjuvant Treatment With or Without Tislelizumab for Locally Advanced Rectal Cancer. (TOTAL)
Acronym TOTAL
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors brenner baruch
Indications
Therapies
Age Groups: adult | senior
Covered Countries ISR | DEU


No variant requirements are available.